Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China

Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China

Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China

Order of the President of the People's Republic of China No.27

April 24, 2015

The Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China, adopted at the 14th Session of the Standing Committee of the 12th National People's Congress of the People's Republic of China on April 24, 2015, is hereby promulgated and shall come into force as of the date of promulgation.

Xi Jinping, President of the People's Republic of China

Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China

(Adopted at the 14th Session of the Standing Committee of the 12th National People's Congress on April 24, 2015)

According to the Decision of the Standing Committee of the National People's Congress on Revising the Drug Administration Law of the People's Republic of China (hereinafter referred to as the "Decision"), the 14th Session of the Standing Committee of the 12th National People's Congress has decided to revise the Drug Administration Law of the People's Republic of China as follows:

I.
  ......
Please consent to the LexisNexis Terms and Conditions and Privacy Policy.